Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Radius Recycling Inc (NQ: RDUS ) 16.98 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Aug 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Radius Recycling Inc < Previous 1 2 3 4 Next > Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021 December 10, 2021 Upgrades According to JP Morgan, the prior rating for Arconic Corp (NYSE: Via Benzinga 10 Biggest Price Target Changes For Friday December 10, 2021 Keybanc boosted the price target on Broadcom Inc. (NASDAQ: Via Benzinga Analyst Ratings For Radius Health October 21, 2021 Analysts have provided the following ratings for Radius Health (NASDAQ:RDUS Via Benzinga 52 Biggest Movers From Yesterday December 09, 2021 Gainers Insignia Systems, Inc. (NASDAQ: ISIG) shares surged 84.1% to close at $19.11 on Wednesday. Insignia Systems recently announced the commencement of a formal process to... Via Benzinga Mid-Afternoon Market Update: Nasdaq Rises 70 Points; Stitch Fix Shares Slide December 08, 2021 Toward the end of trading Wednesday, the Dow traded down 0.08% to 35,692.63 while the NASDAQ rose 0.45% to 15,757.04. The S&P also rose, gaining 0.12% to 4,692.41. The U.S.... Via Benzinga Topics Stocks Exposures US Equities Why Radius Health Stock Is Getting Pummeled Today December 08, 2021 A closer look at the clinical trial results that drove the stock up in October was a little disappointing. Via The Motley Fool 12 Health Care Stocks Moving In Wednesday's Intraday Session December 08, 2021 Gainers Virpax Pharmaceuticals (NASDAQ:VRPX) shares increased by 26.54% to $5.12 during Wednesday's regular session. Trading volume for Virpax Pharmaceuticals's... Via Benzinga Radius Health Reveals Detailed Elacestrant Data From Late-Stage Breast Cancer Trial December 08, 2021 The Menarini Group and Radius Health Inc (NASDAQ: RDUS) have provided details on the elacestrant data from the EMERALD Phase 3 trial presented at the San... Via Benzinga Mid-Day Market Update: Photronics Rises Following Upbeat Q4 Results; Radius Health Shares Slide December 08, 2021 Midway through trading Wednesday, the Dow traded down 0.13% to 35,673.40 while the NASDAQ fell 0.10% to 15,670.88. The S&P also fell, dropping 0.11% to 4,681.64. The U.S. has... Via Benzinga Topics Stocks Exposures US Equities 35 Stocks Moving In Wednesday's Mid-Day Session December 08, 2021 Gainers Insignia Systems, Inc. (NASDAQ: ISIG) shares jumped 79% to $18.63. Insignia Systems recently announced the commencement of a formal process to explore strategic options... Via Benzinga Mid-Morning Market Update: Markets Mixed; United Natural Foods Beats Q1 Views December 08, 2021 Following the market opening Wednesday, the Dow traded up 0.10% to 35,754.05 while the NASDAQ fell 0.09% to 15,672.72. The S&P also rose, gaining 0.06% to 4,689.49. The U.S.... Via Benzinga Topics Stocks Exposures US Equities Radius Health Stock Stares At 52-Week Low After Disappointing Abaloparatide Transdermal Data In Osteoporosis December 08, 2021 Radius Health Inc (NASDAQ: RDUS) posted topline data from Phase 3 wearABLe study evaluating the non-inferiority (NI) of abaloparatide transdermal system (abalo-TDS... Via Benzinga What 5 Analyst Ratings Have To Say About Radius Health November 09, 2021 Over the past 3 months, 5 analysts have published their opinion on Radius Health (NASDAQ: Via Benzinga Radius Health (RDUS) Q3 2021 Earnings Call Transcript November 08, 2021 RDUS earnings call for the period ending September 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial Earnings Outlook For Radius Health November 05, 2021 Radius Health (NASDAQ:RDUS) is set to give its latest quarterly earnings report on Monday, 2021-11-08. Here's what investors need to know before the announcement. Analysts... Via Benzinga Earnings Scheduled For November 8, 2021 November 08, 2021 Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $0.11 per share on revenue of $215.14 million. •... Via Benzinga 48 Biggest Movers From Yesterday October 21, 2021 Gainers Xiaobai Maimai Inc. (NASDAQ: HX) shares surged 98.4% to settle at $18.87 on Wednesday on above-average volume. The company on Tuesday disclosed the resignation of its CEO... Via Benzinga Mid-Afternoon Market Update: Nasdaq Turns Lower; Sesen Bio Shares Surge October 20, 2021 Toward the end of trading Wednesday, the Dow traded up 0.46% to 35,619.52 while the NASDAQ fell 0.19% to 15,100.51. The S&P also rose, gaining 0.28% to 4,532.23. The U.S. has... Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Wednesday's Intraday Session October 20, 2021 Gainers Sesen Bio (NASDAQ:SESN) stock increased by 29.2% to $1.3 during Wednesday's regular session. Trading volume for this security as of 12:30 EST is 149.3 million... Via Benzinga Mid-Day Market Update: Healthcare Services Drops After Q3 Results; Radius Health Shares Jump October 20, 2021 Midway through trading Wednesday, the Dow traded up 0.40% to 35,598.89 while the NASDAQ rose 0.15% to 15,151.71. The S&P also rose, gaining 0.37% to 4,536.47. The U.S. has the... Via Benzinga Topics Stocks Exposures US Equities Why Radius Health Stock Is Exploding Higher Today October 20, 2021 Positive clinical-trial results for a late-stage breast cancer treatment are pushing the stock up. Via The Motley Fool 32 Stocks Moving In Wednesday's Mid-Day Session October 20, 2021 Gainers Sesen Bio, Inc. (NASDAQ: SESN) rose 34.7% to $1.36. The FDA granted Sesen Bio’s request for a Type A meeting to discuss the Chemistry, Manufacturing, and Controls (... Via Benzinga Exposures Product Safety Mid-Morning Market Update: Markets Open Higher; Verizon Posts Upbeat Earnings October 20, 2021 Following the market opening Wednesday, the Dow traded up 0.35% to 35,580.21 while the NASDAQ rose 0.11% to 15,146.02. The S&P also rose, gaining 0.32% to 4,533.97. The U.S.... Via Benzinga Topics Stocks Exposures US Equities Why Are Radius Health Shares Soaring Today? October 20, 2021 The Menarini Group and Radius Health Inc (NASDAQ: RDUS) have announced topline results from the EMERALD Phase 3 study evaluating elacestrant as... Via Benzinga 46 Biggest Movers From Yesterday October 12, 2021 Gainers Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares jumped 93.9% to close at $35.36 on Monday. The FDA removed the full clinical hold on Protagonist Therapeutics’... Via Benzinga Exposures Product Safety 3 Stocks Insiders Are Buying October 04, 2021 When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go... Via Benzinga 3 Stocks Insiders Are Buying September 27, 2021 When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go... Via Benzinga Radius Health Earnings Perspective: Return On Capital Employed September 07, 2021 According to Benzinga Pro data, during Q2, Radius Health (NASDAQ:RDUS) posted sales of $51.80 million. Earnings were up 11.28%, but Radius Health still reported an overall loss of... Via Benzinga Radius Health (RDUS) Q2 2021 Earnings Call Transcript August 07, 2021 RDUS earnings call for the period ending June 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial The Daily Biotech Pulse: Gemini Sinks On Data, Amgen's Migraine Drug Approved In Japan, Liver Congress Gets Underway June 23, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 22) AngioDynamics, Inc. (NASDAQ... Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.